Evidence map›Paper›PMID 26830460›Full record

ArticleeLife2016

Correlated magnetic resonance imaging and ultramicroscopy (MR-UM) is a tool kit to assess the dynamics of glioma angiogenesis.

Michael O Breckwoldt, Julia Bode, Felix T Kurz, Angelika Hoffmann, Katharina Ochs, Martina Ott, Katrin Deumelandt, Thomas Krüwel, Daniel Schwarz, Manuel Fischer and 12 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Large-scale characterization of the microvascular geometry in development and disease by tissue clearing and quantitative ultramicroscopy.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Functional Parameters Derived from Magnetic Resonance Imaging Reflect Vascular Morphology in Preclinical Tumors and in Human Liver Metastases.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  15. Article
  16. Article
  17. Review
  18. In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Michael O BreckwoldtNeuroradiology Department, University Hospital Heidelberg, Heidelberg, Germany.
Julia BodeSchaller Research Group, University of Heidelberg and German Cancer Research Center, Heidelberg, Germany.
Felix T KurzNeuroradiology Department, University Hospital Heidelberg, Heidelberg, Germany.
Angelika HoffmannNeuroradiology Department, University Hospital Heidelberg, Heidelberg, Germany.
Katharina OchsClinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
Martina OttClinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
Katrin DeumelandtClinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
Thomas KrüwelDepartment of Diagnostic and Interventional Radiology, University Medical Center Göttingen, Göttingen, Germany.
Daniel SchwarzNeuroradiology Department, University Hospital Heidelberg, Heidelberg, Germany.
Manuel FischerNeuroradiology Department, University Hospital Heidelberg, Heidelberg, Germany.
Xavier HelluyNeuroradiology Department, University Hospital Heidelberg, Heidelberg, Germany.
David MilfordNeuroradiology Department, University Hospital Heidelberg, Heidelberg, Germany.
Klara KirschbaumNeuroradiology Department, University Hospital Heidelberg, Heidelberg, Germany.
Gergely SoleckiNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Sara ChiblakGerman Cancer Consortium and Heidelberg Institute of Radiation Oncology, National Center for Radiation Research in Oncology, Heidelberg, Germany.
Amir AbdollahiGerman Cancer Consortium and Heidelberg Institute of Radiation Oncology, National Center for Radiation Research in Oncology, Heidelberg, Germany.
Frank WinklerNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Wolfgang WickNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Michael PlattenClinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
Sabine HeilandNeuroradiology Department, University Hospital Heidelberg, Heidelberg, Germany.
Martin BendszusNeuroradiology Department, University Hospital Heidelberg, Heidelberg, Germany.
Björn TewsSchaller Research Group, University of Heidelberg and German Cancer Research Center, Heidelberg, Germany.
Heidelberg University · DEGerman Cancer Research Center · DEUniversity Hospital Heidelberg · DEDeutschen Konsortium für Translationale Krebsforschung · DENational Center for Tumor Diseases · DEUniversitätsmedizin Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neoangiogenesis is a pivotal therapeutic target in glioblastoma. Tumor monitoring requires imaging methods to assess treatment effects and disease progression. Until now mapping of the tumor vasculature has been difficult. We have developed a combined magnetic resonance and optical toolkit to study neoangiogenesis in glioma models. We use in vivo magnetic resonance imaging (MRI) and correlative ultramicroscopy (UM) of ex vivo cleared whole brains to track neovascularization. T2* imaging allows the identification of single vessels in glioma development and the quantification of neovessels over time. Pharmacological VEGF inhibition leads to partial vascular normalization with decreased vessel caliber, density, and permeability. To further resolve the tumor microvasculature, we performed correlated UM of fluorescently labeled microvessels in cleared brains. UM resolved typical features of neoangiogenesis and tumor cell invasion with a spatial resolution of ~5 µm. MR-UM can be used as a platform for three-dimensional mapping and high-resolution quantification of tumor angiogenesis.

Indexed as

Neovascularization, PathologicAnimalsBrain NeoplasmsDisease Models, AnimalFluorescent DyesGliomaMagnetic Resonance ImagingMice, Inbred C57BLMicroscopyStaining and LabelingFluorescent DyesangiogenesismouseMRIneuroscienceTissue ClearingUltramicroscopy

Identifiers

PMID26830460
PMCPMC4755755
OpenAlexW2254102990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.